# Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226)

> **NCT03639181** · PHASE2 · UNKNOWN · sponsor: **Genor Biopharma Co., Ltd.** · enrollment: 53 (estimated)

## Conditions studied

- B-cell Non-Hodgkin's Lymphoma

## Interventions

- **BIOLOGICAL:** GB226

## Key facts

- **NCT ID:** NCT03639181
- **Lead sponsor:** Genor Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-15
- **Primary completion:** 2021-09
- **Final completion:** 2022-12-30
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03639181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03639181, "Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03639181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*